alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
* This order and judgment is not binding precedent, except under the doctrines of

law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

** After examining the briefs and appellate record, this panel has determined unanimously that oral argument would not materially assist the determination of this appeal. See Fed. R. App. P. 34(a); 10th Cir. R. 34.1.9. The case therefore is ordered submitted without oral argument.

UNITED STATES COURT OF APPEALS Filed 8/21/96 TENTH CIRCUIT
JOSEPHINE BROWN, ) ) Plaintiff-Appellant, ) ) vs. ) No. 96-1133 ) (D.C. No. 94-M-1142) ARISTEDES ZAVARAS and ) (D. Colo.) ROBERT FURLONG, ) ) Defendants-Appellees. )

ORDER AND JUDGMENT *
Before TACHA, BALDOCK, and BRISCOE, Circuit Judges **
Plaintiff Josephine Brown claims to be “a woman trapped in a man’s body.” Brown, then an inmate at the Limon Correctional Facility, filed this § 1983 action pro se against prison officials alleging that the officials’ refusal to provide him with estrogen treatments constituted deliberate indifference to his medical needs in violation of the1 Brown filed both his notice of appeal and motion to proceed in forma pauperis

prior to the effective date of the recently enacted amendments to § 1915. Pub. L. No. 104-134, Title VIII, §§ 801-10, 110 Stat. 1321. Accordingly, we apply the law in effect prior to the amendments. White v. Gregory , 87 F.3d 429, 430 (10th Cir. 1996).

-2- Eighth Amendment. See Supre v. Ricketts , 792 F.2d 958 (10th Cir. 1986). The district court dismissed Brown’s Eighth Amendment claim for failure to state a cause of action under Fed. R. Civ. P. 12(b)(6). A panel of this Court reversed and remanded for a factual determination of whether prison officials’ withholding of estrogen treatments from Brown constituted deliberate indifference to his medical needs. Brown v. Zavaras , 63 F.3d 967 (10th Cir. 1995). On remand, the district court granted prison officials’ motion for summary judgment under Fed. R. Civ. P. 56. According to the district court, Brown had failed to refute evidence which prison officials presented indicating that they were in no way deliberately indifferent to Brown’s medical needs. The evidence indicated that prison officials have transferred Brown to the San Carlos Correctional Facility to expedite his medical evaluation. Brown appealed. The district court granted her motion to proceed on appeal in forma pauperis. 28 U.S.C. § 1915(a). 1 Our jurisdiction arises under 28 U.S.C. § 1291. Our review of a grant of summary judgment is de novo. Benne v. International Business Mach. Corp ., 87 F.3d 419, 423 (10th Cir. 1996).-3-

We have reviewed the parties’ briefs, pleadings, affidavits, and entire record before us. We agree with the district court substantially for the reasons set forth in its order granting the prison officials’ motion for summary judgment.
AFFIRMED Entered for the Court,

Bobby R. Baldock Circuit Judge
I 

110TH CONGRESS 

2D SESSION H. R. 5392 

To extend the temporary suspension of duty on Mixtures of N-phenyl-N- 

((trichloromethyl)thio)-benzenesulfonamide, calcium carbonate, and mineral oil. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 12, 2008 

Mr. BROWN of South Carolina introduced the following bill; which was 

referred to the Committee on Ways and Means 

A BILL 

To extend the temporary suspension of duty on Mixtures 

of N-phenyl-N-((trichloromethyl)thio)-benzenesulfonamide, calcium carbonate, and mineral oil. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MIXTURES OF N-PHENYL-N-((TRICHLORO4 METHYL)THIO)-BENZENESULFONAMIDE, CAL5 CIUM CARBONATE, AND MINERAL OIL. 

6 (a) IN GENERAL.—Heading 9902.38.31 of the Har7 monized Tariff Schedule of the United States is amended 

8 by striking ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

mstockstill on PROD1PC66 with BILLS

2 

•HR 5392 IH

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 

mstockstill on PROD1PC66 with BILLS
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5225 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5225

  To suspend temporarily the duty on Propanedioic acid, diethyl ester.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 6, 2008

  Mr. Bonner introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on Propanedioic acid, diethyl ester.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROPANEDIOIC ACID, DIETHYL ESTER.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00       Propanedioic acid,  Free         No change        No change        On or before 12/ ''.
                          diethyl ester                                                      31/2011.......
                          (CAS No. 105-53-
                          3) (provided for
                          in subheading
                          2917.19.70)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Fourth Court of Appeals

San Antonio, Texas

August 21, 2019

No. 04-19-00409-CV

Frederick O. SILVER,

Appellant

v.

TOYOTA MOTOR MANUFACTURING TEXAS, INC., ET AL.,

Appellee

From the 131st Judicial District Court, Bexar County, Texas

Trial Court No. 2019-CI-05365

Honorable Rosie Alvarado, Judge Presiding

O R D E R

By order dated August 6, 2019, the trial court clerk and court reporter were ordered to file 

records limited to the trial court’s order on appellant’s ability to afford costs. In addition, 

appellant was ordered to file a brief no later than thirty days after the date the last record was 

filed that was: (1) in compliance with Rule 38.1 of the Texas Rules of Appellate Procedure; and 

(2) limited to issues addressing the trial court’s order on appellant’s ability to afford costs. The 

clerk’s record was filed on August 8, 2019, and, by order dated August 15, 2019, the clerk of this 

court was ordered to provide appellant with a copy of the record. Because the reporter’s record 

was filed on August 15, 2019, a copy of the reporter’s record was also provided to appellant with 

this court’s August 15, 2019 order. Accordingly, appellant’s brief limited to issues addressing 

the trial court’s order on appellant’s ability to afford costs was not due to be filed until 

September 16, 2019.

On August 19, 2019, appellant filed a brief; however, the brief does not comply with 

Rule 38.1 of the Texas Rules of Appellate Procedure because it contains no citations to the 

record, which was provided to appellant, or to any authorities. See TEX. R. APP. P. 38.1(g), (i). 

Although the brief refers to Rule 145 of the Texas Rules of Civil Procedure, the brief does not 

contain any argument applying Rule 145 to the contentions made. Id. at 37.1(i). Furthermore, 

the brief refers to Rule 18a and to the trial judge having a financial interest; however, the brief 

does not contain any argument regarding how this contention relates to the trial court’s order on 

appellant’s ability to afford costs. Id. It is therefore ORDERED that the brief filed by appellant 

on August 19, 2019 is STRICKEN. Appellant is ORDERED to file a brief in compliance with 
Rule 38.1 which is limited to issues addressing the trial court’s order on appellant’s ability to pay 

costs no later than thirty days from the date of this order.

_________________________________

Beth Watkins, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 21st day of August, 2019.

___________________________________

Keith E. Hottle,

Clerk of Court
I 

110TH CONGRESS 

2D SESSION H. R. 5400 

To designate the facility of the United States Postal Service located at 

160 East Washington Street in Chagrin Falls, Ohio, as the ‘‘Sgt. Michael 

M. Kashkoush Post Office Building’’. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 12, 2008 

Mr. LATOURETTE (for himself, Mr. JORDAN of Ohio, Ms. KAPTUR, Mr. 

KUCINICH, Mr. RYAN of Ohio, Mr. TIBERI, Mr. TURNER, Ms. SUTTON, 

Mr. WILSON of Ohio, Mr. LATTA, Mr. HOBSON, Mrs. JONES of Ohio, and 

Mr. CHABOT) introduced the following bill; which was referred to the 

Committee on Oversight and Government Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 160 East Washington Street in Chagrin Falls, 

Ohio, as the ‘‘Sgt. Michael M. Kashkoush Post Office 

Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SGT. MICHAEL M. KASHKOUSH POST OFFICE 

4 BUILDING. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 160 East Washington Street in 


wwoods2 on PRODPC68 with BILLS
2 

•HR 5400 IH

1 Chagrin Falls, Ohio, shall be known and designated as the 

2 ‘‘Sgt. Michael M. Kashkoush Post Office Building’’. 

3 (b) REFERENCES.—Any reference in a law, map, reg4 ulation, document, paper, or other record of the United 

5 States to the facility referred to in subsection (a) shall 

6 be deemed to be a reference to the ‘‘Sgt. Michael M. 

7 Kashkoush Post Office Building’’. 

Æ 


wwoods2 on PRODPC68 with BILLS
**EXHIBIT
      32.2**




**CERTIFICATION
      PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**


**(18
      U.S.C. SECTION 1350)**




In
      connection with the Quarterly Report of Telanetix, Inc., a Delaware corporation
      (the “Company”), on Form 10-QSB for the quarter ending March 31, 2006, as filed
      with the Securities and Exchange Commission (the “Report”), Richard M. Ono,
      Chief Financial Officer of the Company, does each hereby certify, pursuant
      to
§906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that:




(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




/S/
                RICHARD M. ONORichard
                M. OnoChief
                Financial Officer




Dated:
      May 19, 2006







A
      signed
      original of this written statement required by Section 906 has been
      provided to Telanetix, Inc. and will be retained by Telanetix, Inc. and
      furnished to the Securities and Exchange Commission or its staff upon
      request.
EXHIBIT 31.2



Rule 13a-14(a)/15d-14(a) Certification



I, Alan J. Sandler, certify that:



|   |                                                                                                                                                                                                                                                                                                            | 
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
|1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K for the year ended December 31, 2014 of Puradyn Filter Technologies Incorporated; and                                                                                                                                              
|2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.



|              |  |                                                                                                                        
|------------- |  | -----------------------------------------------------------------------------------------------------------------------
|              |  |                                                                                                                        
|April 1, 2016 |  | /s/ Alan J. Sandler
Alan J. Sandler, Secretary to the Board, Vice President, principal financial and accounting officer
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5281 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5281

 To suspend temporarily the duty on Hexanedioic acid, polymer with 1,2-
     ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 1,3-
                   isobenzofurandione, 2-propenoate.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2008

 Mr. Ferguson introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on Hexanedioic acid, polymer with 1,2-
     ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 1,3-
                   isobenzofurandione, 2-propenoate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. HEXANEDIOIC ACID, POLYMER WITH 1,2-ETHANEDIOL, 2-ETHYL-2-
              (HYDROXYMETHYL)-1,3-PROPANEDIOL AND 1,3-
              ISOBENZOFURANDIONE, 2-PROPENOATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00       Hexanedioic acid,   Free         No change        No change        On or before 12/ ''.
                          polymer with 1,2-                                                  31/2011.......
                          ethanediol, 2-
                          ethyl-2-
                          (hydroxymethyl)-
                          1,3-propanediol
                          and 1,3-
                          isobenzofurandion
                          e, 2-propenoate
                          (CAS No. 77107-23-
                          4) (provided for
                          in subheading
                          3907.99.01)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Filed 6/21/16 In re S.O. CA5

NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS
California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115. IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIFTH APPELLATE DISTRICT

In re S.O. , Person s Coming Under the Juvenile Co urt Law.

TUOLUMNE COUNTY DEPARTMENT OF SOCIAL SERVICES,
Plaintiff and Respondent ,

v.

S.O. , Defendant and Appellant

. F072544
(Super. Ct. No s . JV7385, JV7387,

JV7388)



### OPINION

THE COURT *
APPEAL from orders of the Superior Court of Tuolumne County. Donald Segerstrom, Judge. Carol A. Koenig , under appo intment by the Court of Appeal, for Defendant and Appellant.
Sarah Carrillo , County Counsel, and Cody M. Nesper , Deputy County Counsel,
for Plaintiff and Res pondent.

- ooOoo

-

* Before Hill, P.J., Levy, J. and Peña, J.2

.

In a juvenile dependency proceeding, S.O. (mother) appeals from orders, entered on September 29, 2015, that terminated the dependencies of three of her children, S.L.O., D.H., and S.H., awarded physical custody to their father, T.H., and o rdered once

- a

- month supervised visitation with mother. Mother’s only contention is that the juvenile court erred, at the time of the 12

- month review hearing, by failing to proceed as if the children
were Indi an c hildren pursuant to California Rules of Court, rule 5.482(c). By a separate opinion filed on June 13, 2016, which addressed mother’s appeal
from the orders entered at the 12

- month review hearing, we rejected the same contention she now raises, concluding that sh e forfeited the issue by failing to raise it below. ( In re
S.O. et al. (Jun. 13, 2016, F071404) [nonpub. opn.].) Consequently , her current challenge is now moot. ( In re Audrey D. (1979) 100 Cal.App.3d 34, 39.) Accordingly, the appeal from the court’s S eptember 29, 2015, orders is dismissed as moot.
DISPOSITION The appeal is dismissed.
<PAGE>   1

                        [LETTERHEAD OF ONCOGENE SCIENCE]

                                                               EXHIBIT 10 (g)(v)


                                January 21, 1997


Dr. Fred Reynolds
Calbiochem-Novabiochem Corporation
84 Rogers Street
Cambridge, MA 02142

        RE:     TRADEMARK LICENSE AGREEMENT

Dear Dr. Reynolds:

        Currently, your company has the right to use several trademarks owned
by Oncogene Science, Inc., including the mark "Oncogene Research Products" (the
"ORP Mark"), pursuant to the Trademark License Agreement between you and us
dated August 2, 1995 (the "Agreement"). The Agreement expires on August 2,
1998, and you have requested the right to continue using the ORP Mark beyond
the expiration date.

        By this letter, we agree to extend your company's right to use the ORP
Mark, only, for an additional period of twelve (12) years, through August 1,
2010. You agree to comply with your obligations under the agreement, which will
remain in full force and effect for the ORP Mark until the end of this
extension period. This extension does not apply to any other trademark. If you
agree to these terms, please sign and date the enclosed copy of this letter in
the space provided below and return it to me. Thank you.


                                        Sincerely,

                                        /s/ WALTER P. CARNEY
                                        -------------------------------------
                                        ONCOGENE SCIENCE, INC.
                                        Walter P. Carney, Ph.D.
                                        Vice President & General Manager
                                        Diagnostics


Acknowledged and agreed to:

CALBIOCHEM-NOVABIOCHEM CORPORATION

By: /s/ STELIOS B. PAPADOPOULOS
   --------------------------------
Name: Stelios B. Papadopoulos
     ------------------------------
Date: January 27, 1997
     ------------------------------
Exhibit 32.1


                       Certification Pursuant to 18 U.S.C.
                      Section 1350, as Adopted Pursuant to
                      Section 906 of the Sarbanes-Oxley Act
           of 2002 (Chief Executive Officer & Chief Financial Officer)

         In connection with the filing with the United States Securities and
Exchange Commission of Ultimate Franchise Systems, Inc.'s (the "Company") Annual
Report on Form 10-KSB for the year ended September 30, 2004 (the "Report"), the
undersigned, the Chief Executive Officer of the Company, hereby certify (i) in
my capacity as an officer of the Company, (ii) to each of my own respective
actual knowledge, and (iii) solely for the purpose of compliance with 18 U.S.C.
ss.1350, that:

         (1)      the Report fully complies with the requirements of ss.13(a) or
                  15(d) of the Securities Exchange Act of 1934, as amended; and

         (2)      the information contained in the Report fairly presents, in
                  all material respects, the final condition and results of
                  operations of the Company.

         IN WITNESS WHEREOF, the undersigned have executed this Certificate on
January 13, 2005.


ULTIMATE FRANCHISE SYSTEMS, INC.


By: /s/ Christopher M. Swartz
-------------------------------
Chief Executive Officer &
Chief Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

# AGENCY:

National Science Foundation.

# ACTION:

Notice.

# SUMMARY:

The National Science Foundation is announcing the members of the Senior Executive Service Performance Review Board.

# ADDRESSES:

Comments should be addressed to Branch Chief, Executive Services, Division of Human Resource Management, National Science Foundation, Room W15219, 2415 Eisenhower Avenue, Alexandria, VA 22314.

# FOR FURTHER INFORMATION CONTACT:

Ms. Jennifer Munz at the above address or (703) 292-2478.

# SUPPLEMENTARY INFORMATION:

The membership of the National Science Foundation's Senior Executive Service Performance Review Board is as follows:

Karen Marrongelle, Chief Operating Officer, Chairperson

Wonzie Gardner, Jr., Chief Human Capital Officer and Office Head, Office of Information and Resource Management

Janis Coughlin-Piester, Deputy Office Head, Office of Budget, Finance and Award Management

Sean Jones, Assistant Director, Directorate for Mathematical and Physical Sciences

Erwin Gianchandani, Assistant Director, Directorate for Technology, Innovation and Partnerships

Evan Heit, Division Director, Division of Research on Learning in Formal and Informal Settings, Directorate for Education and Human Resources

Maren Williams, Division Director, Division of Administrative Services, Office of Information and Resource Management

William Malyszka, Division Director, Division of Human Resource Management and PRB Executive Secretary

This announcement of the membership of the National Science Foundation's Senior Executive Service Performance Review Board is made in compliance with 5 U.S.C. 4314(c)(4).

Dated: June 27, 2022.

Suzanne H. Plimpton,

Reports Clearance Officer, National Science Foundation.

[FR Doc. 2022-14083 Filed 6-30-22; 8:45 am]

BILLING CODE 7555-01-P